pioglitazone and metformin hydrochloride
PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE (pioglitazone and metformin hydrochloride) by Takeda is agents: pioglitazone and metformin. Approved for type 2 diabetes mellitus, metformin is appropriate, type 1 diabetes mellitus. First approved in 2015.
Drug data last refreshed 21h ago
agents: pioglitazone and metformin. Pioglitazone Pioglitazone is a thiazolidinedione that depends on the presence of insulin for its mechanism of action. Pioglitazone decreases insulin resistance in the periphery and in the liver resulting in increased insulin-dependent glucose disposal and…
Worked on PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE at Takeda? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Efficacy of Pioglitazone Hydrochloride and Metformin Hydrochloride Tablets on the Patients With Newly Diagnosed Type 2 Diabetes Mellitus Combined With Non-alcoholic Fatty Liver Disease